News - Cubist Pharmaceuticals, Markets & Marketing

Filter

Popular Filters

Opioid-induced constipation market expected to see rapid growth by 2017

Opioid-induced constipation market expected to see rapid growth by 2017

13-10-2013

The global market for opioid-induced constipation will increase significantly from $144.42 million in…

AstraZenecabevenopranCubist PharmaceuticalsEuropeGastro-intestinalsMarkets & MarketingnaloxegolNorth AmericaPharmaceuticalRelistorSalix Pharmaceuticals

Optimer/Cubist’s Dificid poised to challenge Vancocin usage in C. difficile treatment; report

14-09-2011

Less than half of surveyed infectious disease (ID) specialists and only 6% of surveyed internists demonstrated…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMarkets & MarketingNorth AmericaOptimer PharmaceuticalsPharmaceuticalVancocin

Majority of US surveyed MCOs will consider reimbursing novel OPAT agents; report

17-08-2011

According to surveyed physicians in the USA, the use of out-patient parenteral antibiotic therapy (OPAT)…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsForest LaboratoriesIvanzMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalTeflaroTheravanceVibativ

Back to top